Inherited pathogenic variants (PVs) in the CDKN2A tumor suppressor gene are among the strongest risk factors for cutaneous melanoma. Dysregulation of the p16/RB1 pathway may intrinsically limit the activity of MAPK‐directed therapy due to the interplay between the two pathways. In our study, we assessed, for the first time, whether patients...
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2020 (v1)Publication
Little is known on whether melanocortin 1 receptor (MC1R) associated cutaneous melanoma (CM) risk varies depending on histological subtype and body site, and whether tumour thickness at diagnosis (the most important prognostic factor for CM patients) differs between MC1R variant carriers and wild-type individuals. We studied the association...
Uploaded on: March 27, 2023 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2010 (v1)Publication
Background: The incidence of melanoma continues to increase in many countries, and primary prevention of melanoma includes avoidance of sunburn as well as adequate sun protection behavior. The aim of this study was to examine the prevalence of self-reported sun protection behaviors and sunburn in users of the Internet, and to identify the...
Uploaded on: April 14, 2023 -
2010 (v1)Publication
Cutaneous melanoma continues to increase in incidence in many countries, and intentional tanning is a risk factor for melanoma. The aim of this study was to understand how melanoma risk factors, perceived threat and preferences for a suntan relate to intentional tanning. Self-report data were collected on behalf of GenoMEL (www.genomel.org)...
Uploaded on: April 14, 2023